Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Nontuberculous mycobacterial lung disease cases on the rise across U.S.

Publish date:: January 21, 2020

Key clinical point: The incidence and prevalence of nontuberculous mycobacterial lung disease is increasing in most states, especially in women and the elderly.

Major finding: The average rate of yearly change in incidence and prevalence of nontuberculous mycobacterial lung disease was +5.2% and +7.5%, respectively.

Study details: An analysis of patient data from a U.S. managed care claims database between 2008 and 2015.

Disclosures: The study was funded by Insmed; the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases; and the National Heart, Lung, and Blood Institute. The authors reported no conflicts of interest.

Citation:

Winthrop KL et al. Ann Am Thorac Soc. 2019 Dec 13. doi: 10.1513/AnnalsATS.201804-236OC.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Infectious Diseases

Obesity, hypoxia predict severity in children with COVID-19,

Prophylactic HIV treatment in female STI patients is rare,

Combo DAA treatments may benefit patients with resistant HCV genotype 3,

Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide,

Opt-out policy at a syringe service program increased HIV/HCV testing,